Consensus ORPEA

Equities

ORP

FR001400NLM4

Market Closed - Euronext Paris 11:35:14 2024-04-26 am EDT 5-day change 1st Jan Change
12.8 EUR +7.29% Intraday chart for ORPEA +4.49% -24.26%

Evolution of the average Target Price on ORPEA

Price target over the last 5 years

History of analyst recommendation changes

da72d.JJAN16CZvVCXoR1qFZfZGJ26GXQ_AY6mDTuWBD-G0iU.QflOucng7CHA9HUnVMj0etvlSEZpWbvxa1mjPXDK6m5G-H2f0K73Zd3OXA~e283ee727a13cd10f22fab7b7df5b78d
ORPEA : Partial integration of the FY23 results Alphavalue
ORPEA : Ready for a refoundation full of thorns Alphavalue
ORPEA : Allowing for the 1,000-to-1 reverse stock split Alphavalue
ORPEA : Recaps now completed, yet the costly and timely rebuild continues Alphavalue
ORPEA : Target cut by -11.5% Alphavalue
Oddo BHF Cuts Orpea PT, Keeps Underperform Opinion MT
ORPEA : Oddo BHF maintains 'underperform' rating, reduces target CF
ORPEA : A 1,000-to-1 reverse stock split is scheduled to be effective 22 March Alphavalue
ORPEA : Target cut by -9.6% Alphavalue
ORPEA : Another unsuccessful Board overhaul following the completion of the second planned recap Alphavalue
ORPEA : Allowing for the second planned capital increase Alphavalue
ORPEA : Allowing for the first planned capital increase Alphavalue
Oddo BHF Maintains Orpea at Underperform, Reduces PT MT
ORPEA : Oddo BHF keeps its distance from the stock and reduces its target price CF
ORPEA : Gloomier light at the end of the tunnel Alphavalue
ORPEA : When poor(er) results are no longer news Alphavalue
ORPEA : Oddo BHF maintains 'underperform' rating CF
ORPEA : Integrating the 2022 annual report information Alphavalue
ORPEA : Good-looking organic growth amidst a bleak outlook Alphavalue
ORPEA : Integrating the 2,500x dilution Alphavalue
ORPEA : AlphaValue reduces its target further CF
ORPEA : Allowing for the profit warning Alphavalue
ORPEA : A tougher struggle than had initially been predicted Alphavalue
ORPEA : 250x dilution might not be the worst (?) Alphavalue
ORPEA : Partial integration of the FY22 results Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.8 EUR
Average target price
10,975 EUR
Spread / Average Target
+85,642.19%
High Price Target
14,000 EUR
Spread / Highest target
+109,275.00%
Low Price Target
7,900 EUR
Spread / Lowest Target
+61,618.75%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ORPEA

alphavalue Yi Zhong
ODDO BHF
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Quarterly revenue - Rate of surprise